73207-302-41 : NDC 2026 Code

73207-302-41 : Vimseltinib ( Romvimza )

Additionally :

You can get information about “73207-302-41” NDC code in 73207-302-41 in HTML format

HTML | 73207-302-41 in TXT (Plain Text) format

TXT | 73207-302-41 in PDF (Portable Document Format)

PDF | 73207-302-41 in XML format

XML formats.

NDC Code : 73207-302-41 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "73207-302-41",
    "PackageDescription": "1 CARTON in 1 CARTON (73207-302-41)  / 1 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK",
    "NDC11Code": "73207-0302-41",
    "ProductNDC": "73207-302",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Romvimza",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Vimseltinib",
    "DosageFormName": "CAPSULE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250214",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA219304",
    "LabelerName": "Deciphera Pharmaceuticals, LLC",
    "SubstanceName": "VIMSELTINIB",
    "StrengthNumber": "14",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Breast Cancer Resistance Protein Inhibitors [MoA], Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-23",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250214",
    "EndMarketingDatePackage": null,
    "SamplePackage": "Y"
  }
}